Cencora, Inc. COR is well-poised for growth on the back of a robust U.S. Healthcare Solutions business and product launches.

For Cencora, around two-thirds of its overall sales in fiscal 2022 were generated by its top 10 customers. Walgreens and Express Scripts, Cencora's two largest customers, accounted for roughly 27% ...

Amazon, CVS Health and Walgreens — are licking their financial wounds after multibillion-dollar investments in primary care ...

Cencora assumes no obligation to update any ... including $50 million in February in concurrence with Walgreens Boots Alliance's sale of shares. As we look to the balance of the fiscal year ...

Also Read: Walgreens Cashes In: Slashes Cencora Stake Again In Debt-Fighting Move Adjusted gross profit margin was 3.86%, an increase of 16 basis points. Adjusted operating income was $1.2 ...

Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in ...

CONSHOHOCKEN, Pa., February 07, 2025--Cencora, Inc. (NYSE: COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount ...

and troubles for peer firm Walgreens. Cramer’s previous remarks about Cencora, Inc. (NYSE:COR) have called the firm a “money machine” no matter what the circumstances are. This time around ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Design Therapeutics (DSGN – Research Report), Zoetis (ZTS – Research Report) and Cencora (COR ...

The three dominant wholesalers—Cencora (formerly AmerisourceBergen ... Major retail pharmacy chains such as Walgreens, CVS Pharmacy, Kroger, and Albertsons are significant purchasers of ...